Intensity of COX2 expression in cells of soft tissue fibrosarcomas in dogs as related to grade of tumour malignancy

• Autorzy: Nowak M , Madej J.A. , Dziegiel P.
• Języki publikacji: EN

Abstrakty

EN

Using imunohistochemical technique, localisation and intensity of COX2 expression were estimated in canine soft tissue fibrosarcomas. The obtained results were related to tumour grade of malignancy. The material was sampled in the course of surgery from 23 dogs of various breed, 5 to 18 years of age. The presence of COX2 was demonstrated in cell cytoplasm in over 43% tumours. Augmented expression of COX2 was observed in samples of tumours manifesting higher grade of malignancy. Also strong positive correlation was detected (r=0.76) between expression of COX2 and grade of malignancy in the tumours, which might point to the involvement of the enzyme in neoplastic transformation of the cells from which fibrosarcomas derive in dogs.

Słowa kluczowe

EN

cell; fibrosarcoma; dog; cyclooxygenase; expression; animal disease; immunohistochemical technique; tumour malignancy; soft tissue

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2007
• Tom: 51
• Numer: 2
• Opis fizyczny: p.275-279,fig.,ref.

Twórcy

autor

Nowak M

• University of Environmental and Life Sciences, 50-375 Wroclaw, Poland

autor

Madej J.A.

autor

Dziegiel P.

Bibliografia

• 1. Baez J.L., Hendrick M.J., Szofer F.S., Goldkamp D., Sorenmo K.U.: Liposarcomas in dogs: 56 cases (1989- 2000). J Am Vet Med Assoc 2004, 224, 887-891.
• 2. Beam S.L., Rassnick K.M., Moore A.S., Mcdonough S.P.: An Immunohistochemical study of cyclooxygenase- 2 expression in various feline neoplasms. Vet Pathol 2003, 40, 496-500.
• 3. Chang G., Boyle J.O., Yang E.K., Zhang F., Sacks P.G., Shah J.P.: Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999, 59, 991-994.
• 4. Dickens D.S., Kozielski R., Leavey P.J., Timmons C., Cripe T.P.: Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma. J Pediatr Hematol/Oncol 2003, 25, 282-285.
• 5. Epstein R.J.: Human molecular biology: an introduction to the molecular basic of health and disease. Edit. Czelej, Lublin, 2005, pp. 304-309.
• 6. Heller D.A., Clifford C.A., Goldschmidt M.H., Holt D.E., Manfredi M.J., Sorenmo K.U.: Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor. Vet Pathol 2005, 42, 350-353.
• 7. Herschman H.R.: Prostaglandin synthase-2. Biochim Biophys Acta 1996, 1299, 125-140.
• 8. Hida T., Yatabe Y., Achiwa H., Muramatsu H., Kozaki K., Nakamura S., Ogawa M., Mitsudomi T., Sugiura T., Takahashi T.: Increased expressed of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 1998, 58, 3761-3764.
• 9. Masmoudi A., Chevalier T.L., Sabatier L., Soria J.C.: Cyclooxygenase 2 inhibitors and cancer chemoprevention. Bull Cancer 2004, 91, 77-84.
• 10. Nowak M., Dzięgiel P., Dzimira S., Madej J.A.: Immunocytochemical localization of COX2 and HER2 in the epithelium of bitches' mammary gland neoplasm. Medycyna Wet 2005, 61, 1284-1287.
• 11. Nowak M., Madej J.A., Dzięgiel P.: Immunohistochemical localization of COX2 in cells of mammary adenocarcinomas in bitches as related to tumour malignancy grade. Bull Vet Inst Pulawy 2005, 49, 433-437.
• 12. Nowak M., Madej J.A.: Prevalence of neoplasms in domestic animals in Lower Silesia during 2000-2004. Medycyna Wet 2006, 62, 900-904.
• 13. Remmele W., Stegner H.E.: Vorschlag zur einheitlichen Definition eines immunoreaktiven Score (IRS) fur den immunohistochemichen Ostrogenrezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe. Pathologie 1987, 8, 138-140.
• 14. Ristimaki A., Honkanen N., Jankala H., Sipponen P., Harkonen M.: Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997, 57, 1276-1280.
• 15. Ristimaki A., Sivula A., Lundin J., Lundin M., Salminen T., Haglund C., Joensuu H., Isola J.: Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 2002, 62, 632-635.
• 16. Rodrigues S., Bruyneel E., Rodrigue C.M., Shahin E., Gespach C.: Cyclooxygenase 2 and carcinogenesis. Bull Cancer 2004, 91, 61-76.
• 17. Sapierzyński R., Sapierzyńska E.: Mesenchymal neoplasms of the skin and subcutaneous tissue in dogs and cats. Part III. High malignancy sarcomas. Życie wet 2004, 79, 488-492.
• 18. Sheng H., Sho J., Morrow J.D.: Modulation of apoptosis and Bcel-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998, 58, 362-366.
• 19. Subbaramaiah K., Telang N., Ramonetti J.T.: Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 1996, 56, 4424-4429.
• 20. Tsujii M., DuBois R.N.: Alterations in cellular adhesion and apoptosis in epithelial cells overexperssing prostagladin endoperoxide synthase-2. Cell 1995, 83, 493-501.
• 21. Tucker O.N., Dannenberg A.Y., Yang E.K.: Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999, 59, 987-990.
• 22. Weiss S.W., Goldblum J.R.: (ed) Soft tissue tumors. Mosby, St. Louis, London, Philadelphia, Sydney, Toronto, 2001, pp. 6-19.
• 23. Wild P.J., Kunz-Schughart L.A., Stoehr R., Burger M., Blaszyk H., Simon R., Gasser T., Mihatsch M., Sauter G., Hartmann A.: High-throughout tissue microarray analysis of COX2 expression in urinary bladder cancer. Int J Oncol 2005, 27, 385-391.